155-A Moffett Park Drive
Suite 240
Sunnyvale
CA
94089
USA
877-651-2628
408-734-2629
ecm@cormatrix.com
Product Categories
Related Content
June 30, 2016 — CorMatrix Cardiovascular Inc. announced the treatment of the first patients using its CorMatrix Tyke, a ...
June 30, 2016
May 26, 2016 — Ligand Pharmaceuticals Inc. announced the acquisition of economic rights to multiple programs owned by ...
May 26, 2016
March 18, 2016 — CorMatrix Cardiovascular Inc. announced treatment of the first patient to receive their tissue ...
March 18, 2016
September 3, 2014 –CorMatrix Cardiovascular announced that it has received U.S. Food and Drug Administration (FDA) ...
September 03, 2014
CorMatrix Cardiovascular announced that it has received U.S. Food and Drug Administration (FDA) clearance to market the ...
July 25, 2014
July 16, 2014 — CorMatrix Cardiovascular and the Central Clinical Hospital of the Ministry of Interior in Warsaw ...
July 16, 2014April 18, 2014 — New research presented at the 34th annual meeting of the International Society for Heart and Lung ...
April 18, 2014
January 24, 2014 — CorMatrix Cardiovascular Inc. received a patent for an augmented injectable extracellular matrix (ECM ...
January 24, 2014
November 18, 2011 – CorMatrix Cardiovascular Inc. announced that the U.S. Food and Drug Administration (FDA) has granted ...
November 18, 2011
Feature | Stem Cell Therapies| Thomas F. Deering, M.D., FACC, FACP, FHRS, Piedmont Heart Institute, Atlanta
Over the last decade, cardiac stem cell therapy has shown tantalizing but as yet unrealized potential as a treatment for ...
May 19, 2011